Comparison of 2 Beta Blocker Drugs on Peripheral Arterial Disease in Patients With High Blood Pressure
Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
This is a 26-week, prospective double-blind, randomized pilot trial of nebivolol versus an
active control, metoprolol succinate, in patients with established lower-extremity peripheral
artery disease, hypertension, and at least moderate risk for coronary artery disease.